We addressed ambiguities in the distinction between incident versus prevalent cases of IBD under IL-17 blockade by running our meta-analysis on two different scenarios: a conservative best case scenario, by which unclear cases are accounted as incident ones and a more progressive worst case scenario, which defined unclear cases as prevalent ones. Here, IL17A is linked to inflammatory bowel disease.